About this Research Topic
The COVID-19 pandemic has had a significant impact on the epidemiology and etiology of respiratory tract and gastrointestinal infections. The implementation of control measures such as social distancing and hand hygiene was associated with a decrease in the incidence of some respiratory and gastrointestinal infections caused by other viruses and bacteria. Epidemiological data suggest that the incidence of respiratory tract infections other than SARS-CoV-2 infection has decreased during the COVID-19 pandemic, possibly due to the adoption of several non-pharmaceutical interventions in public areas. Currently, there is very little research on the interaction between SARS-CoV-2 and other infectious pathogens in terms of microbiome and virome. As a matter of fact, changes in the epidemiology of respiratory and gastrointestinal infections may be due to other causes than SARS-CoV-2-specific control measures. It is still unclear whether these changes might result from direct interaction between SARS-CoV-2 and the microbiome and/or virome.
Continuous and ongoing efforts to understand the impact of the COVID-19 pandemic on infectious diseases are critical in advancing scientific discovery for prevention and treatment strategies for future pandemics. Through this research theme, we aim to explore scientific gaps related to our understanding of the changes in epidemiology and pathogenic agents responsible for respiratory tract and gastrointestinal infections during the COVID-19 pandemic.
The current Research Topic aims to highlight the latest scientific findings in the following areas:
1. Change in incidence and prevalence of respiratory tract and gastrointestinal infections during the COVID-19 pandemic.
2. Change in the causative agents of respiratory tract and gastrointestinal infections in COVID-19 circulating area.
3. Interaction between SARS-CoV-2 and other pathogens responsible for respiratory and gastrointestinal infections.
4. Microbial and virological changes after infection with SARS-CoV-2.
5. Clinical features and outcomes of patients co-infected with COVID-19 and other respiratory or gastrointestinal pathogens
6. Effectiveness of current treatment and prevention strategies for respiratory tract and gastrointestinal infections during the COVID-19 pandemic
Continuous and ongoing efforts to understand the impact of the COVID-19 pandemic on infectious diseases are critical in advancing scientific discovery for prevention and treatment strategies for future pandemics. Through this research theme, we aim to explore scientific gaps related to our understanding of the changes in epidemiology and pathogenic agents responsible for respiratory tract and gastrointestinal infections during the COVID-19 pandemic.
The current Research Topic aims to highlight the latest scientific findings in the following areas:
1. Change in incidence and prevalence of respiratory tract and gastrointestinal infections during the COVID-19 pandemic.
2. Change in the causative agents of respiratory tract and gastrointestinal infections in COVID-19 circulating area.
3. Interaction between SARS-CoV-2 and other pathogens responsible for respiratory and gastrointestinal infections.
4. Microbial and virological changes after infection with SARS-CoV-2.
5. Clinical features and outcomes of patients co-infected with COVID-19 and other respiratory or gastrointestinal pathogens
6. Effectiveness of current treatment and prevention strategies for respiratory tract and gastrointestinal infections during the COVID-19 pandemic
Keywords: microbiome, virome, Epidemiology, respiratory infections, gastrointestinal infections, COVID-19, infection etiology
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
